Will the U.S. Keep Buying Medicine for ‘Black Swan’ Attacks?

An analytical chemist in Pennsylvania conducts testing for a developmental drug in 2003. Lawmakers are set to consider whether to continue funding a multibillion-dollar program to develop drug treatments for relatively unlikely unconventional attacks.
National Journal
Diane Barnes
Add to Briefcase
Diane Barnes
June 26, 2014, 11 a.m.

Con­gress will weigh this year wheth­er to con­tin­ue spend­ing bil­lions of dol­lars on an­ti­dotes for at­tacks seen as re­l­at­ively un­likely, but po­ten­tially dev­ast­at­ing.

Law­makers helped to es­tab­lish Pro­ject Bioshield in 2004 to in­centiv­ize oth­er­wise un­prof­it­able work on treat­ments for exot­ic pos­sible ter­ror­ism tools, such as an­thrax and botulin­um tox­in. In com­ing months, though, the dec­ade-old ini­ti­at­ive could face un­pre­ced­en­ted scru­tiny of its fund­ing, in part due to a dearth of chem­ic­al, bio­lo­gic­al, ra­di­olo­gic­al and nuc­le­ar at­tacks in the United States since its launch, says a newly pub­lished Con­gres­sion­al Re­search Ser­vice re­port.

“Con­gres­sion­al poli­cy­makers could de­cide not to fund Pro­ject Bioshield,” ana­lyst Frank Got­tron said in the as­sess­ment. “Giv­en the con­tin­ued ab­sence of any [WMD] ter­ror­ist at­tacks in the United States since 2001, [they] could deem that the per­ceived risk of an at­tack no longer jus­ti­fies [the] con­tin­ued in­vest­ment.”

“Al­tern­at­ively, poli­cy­makers could deem oth­er, more con­ven­tion­al, coun­ter­meas­ure pro­cure­ment meth­ods suf­fi­cient or more ef­fi­cient than Pro­ject Bioshield and re­dir­ect fund­ing to those pro­grams,” Got­tron wrote.

Con­gress guar­an­teed Pro­ject Bioshield a steady $560 mil­lion in an­nu­al fund­ing for its first dec­ade by set­ting aside bil­lions in ad­vance. The Health and Hu­man Ser­vices De­part­ment set aside more than half of the pro­gram’s 10-year, $5.6 bil­lion “spe­cial re­serve fund” to ac­quire treat­ments for symp­toms of a wide vari­ety of po­ten­tial un­con­ven­tion­al as­saults. Of the $3.3 bil­lion ear­marked for WMD threats, about one-third went to­ward small­pox drugs, in case the long-erad­ic­ated vir­us is ever re­built or re­leased from a rare labor­at­ory stock­pile.

Law­makers last year au­thor­ized the pro­gram to con­tin­ue re­ceiv­ing the same amount of money through fisc­al 2018. Rather than main­tain­ing its spe­cial re­serve fund, though, they left fund­ing levels to be de­term­ined through the an­nu­al ap­pro­pri­ations pro­cess.

The pro­gram re­ceived $255 mil­lion in fisc­al 2014 ap­pro­pri­ations, and the Obama ad­min­is­tra­tion is seek­ing $415 mil­lion in the up­com­ing budget cycle.

“The switch to an­nu­al ap­pro­pri­ations may com­plic­ate [the Health and Hu­man Ser­vices De­part­ment’s] long-term coun­ter­meas­ure de­vel­op­ment and ac­quis­i­tion plan­ning,” Got­tron wrote. “Some de­velopers con­tend that an ad­vance ap­pro­pri­ation helps com­pany man­age­ment more fa­vor­ably con­sider a po­ten­tial coun­ter­meas­ure when weigh­ing in­tern­al in­vest­ment op­por­tun­ity costs.”

Law­makers may ul­ti­mately re­in­state an ap­proach sim­il­ar to the 10-year re­serve fund, the ana­lyst ad­ded.

“De­velopers might prefer ad­vance ap­pro­pri­ations for as long a peri­od as pos­sible,” he wrote. “However, provid­ing an ad­vance ap­pro­pri­ation dur­ing the cur­rent fisc­al en­vir­on­ment may prove more dif­fi­cult than in 2003.”

What We're Following See More »
CITES CONFLICT OF INTEREST
Lieberman Withdraws from Consideration for FBI Job
2 days ago
THE LATEST
MINIMUM 2 PERCENT GDP
Trump Tells NATO Countries To Pay Up
2 days ago
BREAKING
MANAFORT AND FLYNN
Russians Discussed Influencing Trump Through Aides
2 days ago
THE DETAILS

"American spies collected information last summer revealing that senior Russian intelligence and political officials were discussing how to exert influence over Donald J. Trump through his advisers." The conversations centered around Paul Manafort, who was campaign chairman at the time, and Michael Flynn, former national security adviser and then a close campaign surrogate. Both men have been tied heavily with Russia and Flynn is currently at the center of the FBI investigation into possible collusion between the Trump campaign and Russia.

Source:
BUT WHITE HOUSE MAY USE AGAINST HIM ANYWAY
Ethics Cops Clear Mueller to Work on Trump Case
3 days ago
THE LATEST

"Former FBI Director Robert Mueller has been cleared by U.S. Department of Justice ethics experts to oversee an investigation into possible collusion between then-candidate Donald Trump's 2016 election campaign and Russia." Some had speculated that the White House would use "an ethics rule limiting government attorneys from investigating people their former law firm represented" to trip up Mueller's appointment. Jared Kushner is a client of Mueller's firm, WilmerHale. "Although Mueller has now been cleared by the Justice Department, the White House may still use his former law firm's connection to Manafort and Kushner to undermine the findings of his investigation, according to two sources close to the White House."

Source:
BUSINESSES CAN’T PLEAD FIFTH
Senate Intel to Subpoena Two of Flynn’s Businesses
4 days ago
THE LATEST

Senate Intelligence Committee chairman Richard Burr (R-NC) and ranking member Mark Warner (D-VA) will subpoena two businesses owned by former National Security Advisor Michael Flynn. Burr said, "We would like to hear from General Flynn. We'd like to see his documents. We'd like him to tell his story because he publicly said he had a story to tell."

×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login